Close
Nordic 9Nordic 9

Cure8 Ventures (investor - Venture Capital)

United States cure8ventures.com
See something wrong or missing? Let us know
Offices:St Louis

Cure8 Ventures is an American early-stage firm focused on food, wellness and health

Average round investment:10.44M USD
Average number per year:1.0
Distribution: 2021 (1)
Portfolio companies: Germany Exciva
Mostly invests in: Germany Germany (1) Biotech (1)

1 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Cure8 Ventures

Name Criteria
Luxembourg Vesalius Biocapital Partners
83%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Spain Ekarpen
80%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Israel Nadav Rosenberg
80%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.0
  • Active last 12 months: Yes
Germany LBBW VC
80%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 1.7
  • Active last 12 months: Yes
Germany Creathor Venture
80%
  • Range for average deal size: 5M - 10M USD
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
Norway Sparebank 1 SMN Invest
79%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.4
  • Active last 12 months: Yes
Norway Ferd Capital
79%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Average number of deals per year: 1.5
  • Active last 12 months: Yes
United Kingdom Wellington Partners
78%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 2.6
France Seventure Partners
78%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 2.9
Germany Boehringer Ingelheim Venture Fund
78%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 3.0
Top